Philippe Cestac
Overview
Explore the profile of Philippe Cestac including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
395
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jurado C, Ramjaun Z, El Balkhi S, Saint-Marcoux F, Alonso M, Salabert A, et al.
Hosp Pharm
. 2025 Jan;
:00185787241309254.
PMID: 39744505
Amid the early 2020 SARS-CoV-2 crisis, severe hand sanitizer shortages led to OMS local production recommendations, inviting a diverse array of alcohol producers to contribute. However, not all followed mandatory...
2.
Bou Malham C, El Khatib S, Cestac P, Andrieu S, Rouch L, Salameh P
BMC Prim Care
. 2024 Jun;
25(1):213.
PMID: 38872125
Background: The management of inappropriate medication use in older patients suffering from multimorbidity and polymedication is a major healthcare challenge. In a primary care setting, a medication review is an...
3.
Guillotin S, Fulzele A, Vallet A, Gonzalez de Peredo A, Mouton-Barbosa E, Cestac P, et al.
Aging Cell
. 2024 May;
23(7):e14168.
PMID: 38698559
Frailty is a clinical state reflecting a decrease in physiological reserve capacities, known to affect numerous biological pathways and is associated with health issues, including neurodegenerative diseases. However, how global...
4.
El Khatib S, Bou Malham C, Andrieu S, Strumia M, Cestac P, Salameh P
BMC Geriatr
. 2024 Apr;
24(1):327.
PMID: 38600461
Background: Falling is a major concern for the health of older adults and significantly affects their quality of life. Identifying the various risk factors and the differences between older patients...
5.
Bencivenga L, Strumia M, Rolland Y, Guyonnet S, Parini A, Cestac P, et al.
Eur J Intern Med
. 2024 Mar;
125:82-88.
PMID: 38499456
Background: The effectiveness of the body physiological regulatory mechanisms declines in late life, and increased Blood Pressure Variability (BPV) may represent an alteration in cardiovascular homeostatic patterns. Intrinsic Capacity (IC)...
6.
Aghnatios L, Rofes G, Sorli S, Cestac P, Pages A, Eyvrard F
Sante Publique
. 2024 Feb;
35(6):39-51.
PMID: 38388400
Introduction: In response to the COVID-19 pandemic, France was under lockdown for the first time from March 17 to May 10, 2020. Purpose Of The Research: The aim of this...
7.
Taillefer de Laportaliere T, Jullien A, Eyvrard F, Yrondi A, Montastruc F, Cestac P, et al.
Encephale
. 2023 Dec;
50(4):469-472.
PMID: 38040510
In France, the funding of mental health institutions relies on an annual budget allocation. Esketamine, a non-competitive NMDA glutamate receptor antagonist, has been approved for adults with treatment-resistant major depressive...
8.
Novais T, Qassemi S, Cestac P, McCambridge C, Villars H, Decaudin B, et al.
Int J Clin Pharm
. 2023 Aug;
46(1):205-209.
PMID: 37532841
Background: Patients with Alzheimer's disease and related dementias and their caregivers can be defined as people with higher risk of developing medication-related problems due to aging and polypharmacy. Aim: To...
9.
Novais T, Qassemi S, Cestac P, McCambridge C, Villars H, Zueras A, et al.
Contemp Clin Trials Commun
. 2023 Jul;
33:101146.
PMID: 37397433
Background: Psychosocial interventions for caregivers of patients with Alzheimer disease and relative dementias (ADRD) reported a caregiver burden improvement. Multicomponent intervention integrating pharmaceutical care has not yet been evaluated while...
10.
Taillefer de Laportaliere T, Jullien A, Yrondi A, Cestac P, Montastruc F
Psychol Med
. 2023 May;
53(10):4305-4315.
PMID: 37185130
While previous systematic reviews of trials evaluating conventional antidepressants highlighted inadequacies and inconsistencies in adverse event (AE) reporting, no evaluation is available on esketamine in resistant depression. The objective of...